Internal Medicine · Columbia, SC
NPI
1770543621
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4100 N. Main St, Suite 203
Columbia, SC, 29203
Phone (803) 754-0006
Groups this clinician bills Medicare through
Medicare paid, 2024
$282K
5,798 services
Medicare patients, 2024
319
Average age 76
Drug cost, 2024
$1.4M
10,677 prescriptions
Company payments, 2025
$953
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Albert Humphrey was code 99490 (chronic, principal, and transitional care management), 1,945 times for 205 patients. In total Albert Humphrey billed 5,798 services in 42 codes, and Medicare paid $282K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,945 | 205 | $44.49 | $87K |
| 99214 Office E&M - Established | Office | 1,405 | 304 | $81.55 | $115K |
| 81003 Clinical Chemistry | Office | 308 | 206 | $2.20 | $678 |
| 99497 Care Management/Coordination | Office | 235 | 231 | $75.38 | $18K |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 229 | 229 | $17.32 | $3,966 |
| G0446 Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 227 | 227 | $23.74 | $5,389 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 216 | 216 | $117.78 | $25K |
| 96372 Injection Administration | Office | 180 | 52 | $9.95 | $1,790 |
| 82044 Clinical Chemistry | Office | 156 | 130 | $6.08 | $948 |
| 82570 Clinical Chemistry | Office | 115 | 95 | $5.05 | $580 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 110 | 38 | $0.96 | $105 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 97 | 71 | $12.23 | $1,187 |
| 99211 Office E&M - Established | Office | 96 | 32 | $15.76 | $1,513 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 82 | 82 | $23.75 | $1,948 |
| G0136 Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes | Office | 78 | 78 | $15.21 | $1,187 |
By year: 2022 $257K for 4,477 services; 2023 $253K for 4,705 services; 2024 $282K for 5,798 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 308 | 206 | $2.20 | $678 |
| 82044 Clinical Chemistry | 156 | 130 | $6.08 | $948 |
| 82570 Clinical Chemistry | 115 | 95 | $5.05 | $580 |
| 82962 Clinical Chemistry | 17 | 15 | $3.21 | $54.57 |
| 83036 Blood Count | 16 | 16 | $9.52 | $152 |
Medicare prescription drug claims, 2024
In 2024, the drug Albert Humphrey prescribed most often to Medicare patients was Oxycodone Hcl, with 724 prescriptions and refills. In total Albert Humphrey wrote 10,677 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 724 | 724 | 89 | $29K |
| Atorvastatin Calcium Generic | 537 | 1,558 | 178 | $8,038 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 461 | 461 | 71 | $15K |
| Methadone Hcl Generic | 418 | 418 | 54 | $10K |
| Morphine Sulfate Er Morphine Sulfate | 248 | 248 | 26 | $10K |
| Hydromorphone Hcl Generic | 244 | 244 | 33 | $12K |
| Amlodipine Besylate Generic | 234 | 623 | 77 | $1,187 |
| Metformin Hcl Generic | 229 | 610 | 74 | $1,749 |
| Repatha Sureclick Evolocumab | 210 | 279 | 56 | $153K |
| Rosuvastatin Calcium Generic | 201 | 555 | 69 | $3,705 |
| Gabapentin Generic | 200 | 373 | 57 | $2,767 |
| Levothyroxine Sodium Generic | 199 | 542 | 60 | $2,734 |
| Carvedilol Generic | 197 | 530 | 70 | $1,826 |
| Furosemide Generic | 195 | 487 | 74 | $901 |
| Losartan Potassium Generic | 184 | 526 | 63 | $2,451 |
Brand drugs: 1,735 claims; generic drugs: 8,822 claims; opioid claims: 2,878.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Albert Humphrey $953 ($953 in general payments such as food, travel and fees) from 18 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $252.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 7 | $252 |
| Esperion Therapeutics, Inc. ESPR | 4 | $114 |
| Novo Nordisk Inc NVO | 5 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $77.37 |
| Abbott Laboratories ABT | 3 | $57.7 |
| CeQur Corporation | 1 | $50 |
| Amgen Inc. AMGN | 2 | $44.7 |
| Lilly USA, LLC LLY | 2 | $44.19 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $33.9 |
| Abiomed JNJ | 1 | $30.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.